Palliative care is comprised of an interdisciplinary team (IDT) approach with members from different disciplines who collaboratively work together to reduce multidimensional components of pain and suffering and improve quality of life for patients coping with a terminal illness. Psychosocial team members are integral to the palliative care IDT and provide expertise in assessment and empirically validated interventions to address psychological distress. The following paper will provide a review of different facets of psychological distress experienced by advanced cancer patients such as psychological disorders, existential distress, spiritual distress, caregiver distress, parental distress, and grief. Finally, an overview of commonly used screening and assessment tools as well as psychological interventions relevant for the palliative care population is presented.
Citations
Citations to this article as recorded by
The Experience of Reflexive Hospice Care for Patients With Advanced Cancer: A Qualitative Study Xi Zhang, Tieying Zeng, Ye Chen Journal of Clinical Nursing.2025; 34(1): 247. CrossRef
Enfoque global en la atención al final de vida. Aspectos médico-legales, éticos, sociales, psicológicos y de cuidados Josep Arimany-Manso, Francesc Torralba, Ana Isabel Lima, María Die Trill Medicina Clínica.2025; 164(3): e8. CrossRef
A comprehensive approach to end-of-life care. Medical-legal, ethical, social, psychological and care aspects Josep Arimany-Manso, Francesc Torralba, Ana Isabel Lima, María Die Trill Medicina Clínica (English Edition).2025; 164(3): e8. CrossRef
Transforming End-of-Life Care: Impact of the “Melhor em Casa” Home-Based Palliative Care Program in Brazil Mônica Isaura Corrêa, Eduardo Bruera, Júnia de Oliveira Alves, Sonia Souza, Marília Ávila de Freitas Aguiar, Ana Paula Drummond-Lage Journal of Palliative Medicine.2025; 28(7): 917. CrossRef
Social Issues and Emotional Distress amongst Patients with Cancer Receiving Palliative Care in a Tertiary Cancer Centre T. Rohini, Simi Mohan, Josna Jesmon, P. Sreetha, M.S. Biji Indian Journal of Palliative Care.2025; 31: 235. CrossRef
Expanding Psycho‐Oncology Services in India: Perspectives From Physicians in Cancer Care Centres Bincy Mathew, Wendy W. T. Lam, Saipriya Tiwari, Melissa Henry Psycho-Oncology.2025;[Epub] CrossRef
Family Caregivers’ Perspectives on the Potential of Drone-Based Medication Delivery in Palliative Home Care: Qualitative Focus Group Study Franziska Fink, Sabrina Claudia Otto, Martin Grünthal, Anne Lehmann, Patrick Jahn JMIR Human Factors.2025; 12: e80320. CrossRef
Providing psychological support to people impacted by terminal illness: A mixed methods study of hospice staff perceived competence, confidence and training needs Fatema Zavery, Sulafa Fakhreddin, Sarah Huibregtse Van Loon, Mhairi McDougall, Anne Finucane, Antony Bayer, PLOS One.2025; 20(9): e0331680. CrossRef
A qualitative exploratory description of the psychosocial challenges of cancer patients receiving palliative care at a major teaching hospital in Ghana Yvonne Owusu, Merri Iddrisu, Tabitha Gyanewaa Quaidoo, Frema Osei-Tutu, Hadiru Iddris Mumuni, Ayisha Adwoa Boateng Discover Psychology.2025;[Epub] CrossRef
Intervention effect of virtual reality (VR) marathon simulation training on psychological disinhibition in bedridden cancer patients Xinkai Zhang, Ziyu Wang, Zifu Xu, Li Wang, Qi Liu, Gang Qin Psycho-Oncologie.2025; 19(4): 4691. CrossRef
Psychosocial Distress Screening Among Interprofessional Palliative Care Teams: A Narrative Review Chelsea K. Brown, Cara L. Wallace Journal of Social Work in End-of-Life & Palliative Care.2024; 20(2): 161. CrossRef
Diagnostic and therapeutic strategies in pancreatic adenosquamous carcinoma: Molecular and clinical insights in managing metastatic disease Nathaniel Grabill, Mena Louis, Mariah Cawthon, Claudia Gherasim, James Chambers Radiology Case Reports.2024; 19(12): 6016. CrossRef
Perceived Shame and Stigma, and Other Psychosocial Predictors of Psychological Distress Among Cancer Patients in Malaysia Hui Ting Eyu, Nik Ruzyanei Nik Jaafar, Mohammad Farris Iman Leong Abdullah, Hajar Mohd Salleh Salimi, Mohd Razif Mohamad Yunus, Fuad Ismail, Nur Fa'izah Ab Muin, Noor Syazwani Abdul Aziz Psycho-Oncology.2024;[Epub] CrossRef
Acceptance and Commitment Therapy (ACT) for people with advanced progressive illness, their caregivers and staff involved in their care: A scoping review Tilly Gibson Watt, David Gillanders, Juliet A Spiller, Anne M Finucane Palliative Medicine.2023; 37(8): 1100. CrossRef
Palliative care competence among medical students Úrsula Bueno do Prado Guirro, Carla Corradi Perini, Luís Otávio Zatorre Fileno, Gustavo Belam Fioravanti, José Eduardo de Siqueira Revista Bioética.2023;[Epub] CrossRef
Competencias en cuidados paliativos entre los estudiantes de medicina Úrsula Bueno do Prado Guirro, Carla Corradi Perini, Luís Otávio Zatorre Fileno, Gustavo Belam Fioravanti, José Eduardo de Siqueira Revista Bioética.2023;[Epub] CrossRef
Competências em cuidados paliativos entre estudantes do curso de medicina Úrsula Bueno do Prado Guirro, Carla Corradi Perini, Luís Otávio Zatorre Fileno, Gustavo Belam Fioravanti, José Eduardo de Siqueira Revista Bioética.2023;[Epub] CrossRef
La espiritualidad desde la mirada de Terapia Ocupacional en el contexto de los Cuidados Paliativos Carla Mondelo Revista Terapéutica.2023; 17(1): 9. CrossRef
Accurate prediction of impending death (i.e., last few days of life) is essential for terminally-ill cancer patients and their families. International guidelines state that clinicians should identify patients with impending death, communicate the prognosis with patients and families, help them with their end-of-life decision-making, and provide sufficient symptom palliation. Over the past decade, several national and international studies have been conducted that systematically investigated signs and symptoms of impending death as well as how to communicate such a prognosis effectively with patients and families. In this article, we summarize the current evidence on prognostication and communication regarding the last days of life of patients with cancer, and future directions of clinical research.
Citations
Citations to this article as recorded by
Case report: Poor prognosis or poor prognostication? Jacqueline Tschanz, Rida Khan, Eduardo Bruera Palliative and Supportive Care.2025;[Epub] CrossRef
Effectiveness of palliative postural care in alleviating pain and psychological distress in terminal cancer patients Jia Fu, Yu Liu, Mei Zhang, Lili He Asian Journal of Surgery.2025; 48(5): 3253. CrossRef
Determining timeframes to death for imminently dying patients: a retrospective cohort study Tricia O’Connor, Wai-Man Liu, Juliane Samara, Joanne Lewis, Karen Strickland, Catherine Paterson BMC Palliative Care.2025;[Epub] CrossRef
High specificity clinical signs of impending death: A scoping review Catarina Simões, Rui Carneiro, Abílio CardosoTeixeira International Journal of Nursing Studies.2025; 164: 105015. CrossRef
Antibiotics at life’s end: key role in treating end-of-life pneumonia? Thibaut Fraisse, Alain Putot, Emmanuel Forestier, Gaëtan Gavazzi, Petra Vayne-Bossert, Claire Roubaud-Baudron, Virginie Prendki Expert Review of Respiratory Medicine.2025; 19(4): 279. CrossRef
Days spent with healthcare contact by patients with metastatic castrate resistant prostate cancer in the last year of life Daniel Sentana-Lledo, Amelia Barnett, David J Einstein, Arjun Gupta, Alicia K Morgans The Oncologist.2025;[Epub] CrossRef
Prognostication in advanced cancer: foreseeing from global insights and foretelling in the Asian context Yusuke Hiratsuka, Jun Hamano, Masanori Mori, Sang-Yeon Suh, David Hui Japanese Journal of Clinical Oncology.2025; 55(9): 991. CrossRef
Ethical issues in communication in a tertiary oncology center: exploratory survey Elena Ruggiero, Stefania Schiavon, Silvia Stragliotto, Ivan Gallio, Fabio Formaglio, Marina Lorusso, Alessandra Feltrin, Marco Maruzzo, Antonella Brunello Frontiers in Psychology.2025;[Epub] CrossRef
How to distinguish opioid toxicity from natural dying in patients with advanced illness and how to manage opioid toxicity? Jason W. Boland, Elaine G. Boland Clinical Medicine.2025; 25(6): 100510. CrossRef
Prevalence of Triggers and Patient Harm Identified by Global Trigger Tool in Specialized Palliative Care Olav Magnus S. Fredheim, Espen Klingenberg, Anne Karin Lindahl Journal of Palliative Medicine.2024; 27(6): 742. CrossRef
Uso degli antibiotici nel fine vita Matteo Moroni, Massimo Melo, Raffaella Antonione, Massimo Fantoni, Roberto Luzzati, Massimiliano Lanzafame, Rita Murri, Fabio Gilioli, Francesco Dentali, Dario Manfellotto, Biancamaria Fraccaro, Luigi Patil Italian Journal of Medicine.2024;[Epub] CrossRef
Using Performance Status to Identify Risk of Acute Care Transfer in Inpatient Cancer Rehabilitation Keara McNair, Amanda Botticello, Michael D. Stubblefield Archives of Physical Medicine and Rehabilitation.2024; 105(5): 947. CrossRef
Indian Society of Critical Care Medicine and Indian Association of Palliative Care Expert Consensus and Position Statements for End-of-life and Palliative Care in the Intensive Care Unit Sudeep Gupta, Arun Kumar, Roli Mathur, Roop Gursahani, Sushma Bhatnagar, Jayita Deodhar, Prashant Nasa, Raj Kumar Mani, Naveen Salins, Priyadarshini Kulkarni, Srinagesh Simha, Jigeeshu V Divatia, Sheila N Myatra, Dhvani Mehta, Rajani S Bhat, Savita Butola Indian Journal of Critical Care Medicine.2024; 28(3): 200. CrossRef
Comparison of Prognostic Abilities of Palliative Prognostic Index, Laboratory Prognostic Score, and Palliative Prognostic Score Norihiro Yuasa, Natsuko Kawai, Junichi Takamizawa Journal of Pain and Symptom Management.2024; 68(2): 153. CrossRef
Management of Infections in Palliative Care Patients at the End-of-Life and Active Process of Death: A Brazilian Retrospective Study Isabela Fernandes de Aguiar Tonetto, Angelita Maria Stabile, Dieyeni Yuki Kobayasi, Rita de Cássia Quaglio, Ana Carolina de Souza, Fabiana Bolela Palliative Medicine Reports.2024;[Epub] CrossRef
Fatores Associados ao Karnofsky Performance Status e sua Trajetória no Último Mês de Vida em Pacientes com Câncer Terminal Andrezza Helena Regadas Muniz, Karla Santos da Costa Rosa, Juliana Miranda Dutra de Resende, Simone Garruth dos Santos Machado Sampaio, Livia Costa de Oliveira Revista Brasileira de Cancerologia.2023;[Epub] CrossRef
‘It’s not just about me’: a qualitative study of couples’ narratives about home death when one of the partners is dying of cancer Margareta Aurén-Møkleby, Lisbeth Thoresen, Anne Marit Mengshoel, Kari N. Solbrække, Gunvor Aasbø Palliative Care and Social Practice.2023;[Epub] CrossRef
Appetite and its association with mortality in patients with advanced cancer – a Post-hoc Analysis from the Palliative D-study Charlotte Goodrose-Flores, Stephanie E. Bonn, Caritha Klasson, Maria Helde Frankling, Ylva Trolle Lagerros, Linda Björkhem-Bergman BMC Palliative Care.2023;[Epub] CrossRef
Overtreatment in end-of-life care: how can we do better? Linda Björkhem-Bergman Acta Oncologica.2022; 61(12): 1435. CrossRef
Purpose The response to haloperidol as a first-line neuroleptic and the pattern of neuroleptic rotation after haloperidol failure have not been well defined in palliative care. The purpose of this study was to determine the efficacy of haloperidol as a first-line neuroleptic and the predictors associated with the need to rotate to a second neuroleptic. Materials and Methods We conducted a retrospective review of the charts of advanced cancer patients admitted to our acute palliative care unit between January 2012 and March 2013. Inclusion criteria were a diagnosis of delirium and first-line treatment with haloperidol. Results Among 167 patients with delirium, 128 (77%) received only haloperidol and 39 (23%) received a second neuroleptic. Ninety-one patients (71%) who received haloperidol alone improved and were discharged alive. The median initial haloperidol dose was 5 mg (interquartile ranges [IQR], 3 to 7 mg) and the median duration was 5 days (IQR, 3 to 7 days). The median final haloperidol dose was 6 mg (IQR, 5 to 7 mg). A lack of treatment efficacy was the most common reason for neuroleptic rotation (87%). Significant factors associated with neuroleptic rotation were inpatient mortality (59% vs. 29%, p=0.001), and being Caucasian (87% vs. 62%, p=0.014). Chlorpromazine was administered to 37 patients (95%) who were not treated successfully by haloperidol. The median initial chlorpromazine dose was 150 mg (IQR, 100 to 150 mg) and the median duration was 3 days (IQR, 2 to 6 days). Thirteen patients (33%) showed reduced symptoms after the second neuroleptic. Conclusion Neuroleptic rotation from haloperidol was only required in 23% of patients with delirium and was associated with inpatient mortality and white race.
Citations
Citations to this article as recorded by
Proportional Sedation for Persistent Agitated Delirium in Palliative Care David Hui, Allison De La Rosa, Jaw-Shiun Tsai, Shao-Yi Cheng, Egidio Del Fabbro, Anita Thankam Thomas Kuzhiyil, Kendra Rowe, Ahsan Azhar, Thuc Nguyen, Michael Tang, Chien-An Yao, Hsien-Liang Huang, Jen-Kuei Peng, Wen-Yu Hu, Sonal Admane, Rony Dev, Minxing JAMA Oncology.2025; 11(9): 1031. CrossRef
Naming racism as a root cause of inequities in palliative care research: a scoping review Kavita Algu, Joshua Wales, Michael Anderson, Mariam Omilabu, Thandi Briggs, Allison M. Kurahashi BMC Palliative Care.2024;[Epub] CrossRef
Management of Physical Symptoms in Patients with Advanced Cancer during the Last Weeks and Days of Life Ahsan Azhar, David Hui Cancer Research and Treatment.2022; 54(3): 661. CrossRef
Chlorpromazine as Treatment for Refractory Agitation Associated with Pediatric Delirium Shin Young Kim, Shari Simone, Omayma A. Kishk, Ana Lia Graciano, Hyunuk Seung, Sarah Edwards The Journal of Pediatric Pharmacology and Therapeutics.2022; 27(8): 725. CrossRef
Pharmacological and non-pharmacological treatment of delirium in an oncological hospital service: an integrative review Luciana Aparecida Vieira Louro, João Francisco Possari, Antônio Fernandes Costa Lima Revista Brasileira de Enfermagem.2021;[Epub] CrossRef
Neuroleptic strategies for terminal agitation in patients with cancer and delirium at an acute palliative care unit: a single-centre, double-blind, parallel-group, randomised trial David Hui, Allison De La Rosa, Annie Wilson, Thuc Nguyen, Jimin Wu, Marvin Delgado-Guay, Ahsan Azhar, Joseph Arthur, Daniel Epner, Ali Haider, Maxine De La Cruz, Yvonne Heung, Kimberson Tanco, Shalini Dalal, Akhila Reddy, Janet Williams, Sapna Amin, Terri The Lancet Oncology.2020; 21(7): 989. CrossRef
A Scoping Review to Map Empirical Evidence Regarding Key Domains and Questions in the Clinical Pathway of Delirium in Palliative Care Peter G. Lawlor, Nicole A. Rutkowski, Alistair R. MacDonald, Mohammed T. Ansari, Lindsey Sikora, Franco Momoli, Salmaan Kanji, David K. Wright, Erin Rosenberg, Annmarie Hosie, Jose L. Pereira, David Meagher, Jill Rice, John Scott, Shirley H. Bush Journal of Pain and Symptom Management.2019; 57(3): 661. CrossRef
Prevalencia de delirium mediante la escala Memorial Delirium Assessment Scale (MDAS) en pacientes oncológicos avanzados ingresados en una Unidad de Cuidados Paliativos. Factores de riesgo, reversibilidad y tratamiento recibido Verónica Díaz García, Miriam López Pérez, Yolanda Zuriarrain Reyna Medicina Paliativa.2018; 25(4): 245. CrossRef
Clinical Assessment and Management of Delirium in the Palliative Care Setting Shirley Harvey Bush, Sallyanne Tierney, Peter Gerard Lawlor Drugs.2017; 77(15): 1623. CrossRef
Delirium Management: Diagnosis, Assessment, and Treatment in Palliative Care Min Seok Seo, Yong Joo Lee The Korean Journal of Hospice and Palliative Care.2016; 19(3): 201. CrossRef
Neuroleptics in the management of delirium in patients with advanced cancer David Hui, Rony Dev, Eduardo Bruera Current Opinion in Supportive & Palliative Care.2016; 10(4): 316. CrossRef
Acute symptomatic complications among patients with advanced cancer admitted to acute palliative care units: A prospective observational study David Hui, Renata dos Santos, Suresh Reddy, Maria Salete de Angelis Nascimento, Donna S Zhukovsky, Carlos Eduardo Paiva, Shalini Dalal, Everaldo Donizeti Costa, Paul Walker, Heloisa Helena Scapulatempo, Rony Dev, Camila Souza Crovador, Maxine De La Cruz, Palliative Medicine.2015; 29(9): 826. CrossRef